Welcoming Speech

Dear colleagues and friends,

With the aging of the population, the incidence of heart valvular disease is increasing rapidly, which is a serious threat to human life and health.The percutaneous interventional therapy of cardiac valvular disease is becoming more and more mature, which opens a new era in the treatment of cardiac valvular disease.In recent years, China Valve (China Valve) interventional diagnosis and treatment work rapid development, has made remarkable achievements.

Important Information

January 1, 2020 - April 14, 2020

Pre-registration

April 17, 2020 - April 19, 2020

Conference Date

April 18, 2020 14:00

Registration End

April 19, 2020

Closing Ceremony

¥1000

Pre-registration Fee

¥1200

Registration Fee

Review